150 results on '"Massabeau C"'
Search Results
2. Perspectives thérapeutiques dans la prise en charge des CBNPC de stade III non résécables: Therapeutic advances for the management of unresectable stage III Non-Small Cell Lung Cancer
3. Les cancers bronchiques non à petites cellules oligométastatiques: définition et prise en charge
4. La radiothérapie stéréotaxique: indication et résultats dans les stades précoces
5. Radiothérapie guidée par l’image dans le cancer du poumon
6. OC-0261 Impact of radiation to host immune system in patients treated for locally advanced NSCLC
7. Prise en charge des cancers bronchiques non à petites cellules oligométastatiques: Management of non-small oligometastatic lung cancer: Update 2020
8. Traitements locaux : indication et résultats dans les stades précoces: Local treatments: Indication and results in early stages
9. Efficacy of a global supportive skin care programme with hydrotherapy after non‐metastatic breast cancer treatment: A randomised, controlled study
10. Carcinome canalaire in situ avec micro-invasion : spécificités anatomopathologiques et implications cliniques
11. Cours du GOLF 2018 à Toulouse, France
12. Reconstructions mammaires immédiates ou différées : critères de choix et de faisabilité
13. Que faut-il associer à la radiothérapie dans les stades III des CBNPC et comment ?
14. Potential benefits of using cardiac gated images to reduce the dose to the left anterior descending coronary during radiotherapy of left breast and internal mammary nodes
15. PO-1272 SBRT for oligoprogressive/oligorecurrent SCLC: is it worth it?
16. PD-0749 Systemic treatment and ablative therapies in oligometastatic breast cancer: a single center analysis
17. Forme avancée de carcinome infiltrant
18. Les progrès de la radiothérapie dans la prise en charge des cancers bronchiques
19. 1291O Radiotherapy boost to 74 Gy based on FDG-PET at 42 Gy of radiochemotherapy (RCT) in patients with inoperable stage III non-small cell lung cancer (RTEP7 – IFCT 1401): A prospective multicentre, open-label, randomised, controlled trial
20. Fracture de côte suite à la radiothérapie peropératoire dans le cancer du sein. Cas clinique et expérience locale
21. 320P Oligometastatic breast cancer incidence and clinical presentation at diagnosis: About 131 cases
22. OC-0594 Acute toxicity results after breast-conserving therapy in “boost vs no boost (BONBIS)” DCIS trial
23. Variabilité multicentrique de l’estimée du volume tumoral métabolique total en TEP au FDG dans le cadre du PHRC multicentrique RTEP7
24. Helical Tomotherapy (HT) for Postmastectomy Radiation Therapy (PMRT) Treatment after Implant Breast Reconstruction
25. Abstract P3-12-10: First 6-month report of the longitudinal PHACS study (Pharmacology and Hormonotherapy (HT) for Adjuvant breast Cancer (BC) Study, NCT01127295)
26. Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study
27. Toxicité aiguë de la tomothérapie des cancers mammaires
28. PO-0812: Dosimetric impact of using Acuros algorithm for stereotactic lung and spine treatments
29. Variabilité multicentrique de l’estimée du volume tumoral métabolique total en TEP au FDG dans le cadre du PHRC multicentrique RTEP7-IFCT-1402
30. P13. Spine SBRT: Benefit of Magnetic Resonance Imaging acquisition in treatment position and first results of Volumetric Modulated Arc Therapy dose plan
31. PO-0685: Locally advanced breast cancer patients with >7 pN+ axillary lymph nodes treated without axillary irradiation
32. SP-0598: Cilengitide in continuous infusion with radio-chemotherapy in stage III NSCLC: A phase I clinical trial
33. Outcome of pN0 Triple-Negative Breast Cancers With and Without Lymph Node Irradiation
34. Continuous Infusion of Cilengitide with Radio-Chemotherapy in Stage III Nsclc: a Phase I Study
35. Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient: Case report and review of the literature
36. Rapidarc vs. tomotherapy for the treatment of chestwall and lymph nodes: A comparative study
37. SP-25: Continuous Infusion of Cilongitide with Radiochemotherapy in State III NSCL Carcinoma = A Phase 1 Study
38. 761 poster IMPLANT BREAST RECONSTRUCTION FOLLOWED BY RADIOTHERAPY: CAN THE TOMOTHERAPY BECOME A STANDARD OF IRRADIATION?
39. 769 poster POTENTIAL BENEFITS OF USING CARDIAC GATED IMAGES TO REDUCE THE DOSE TO THE LEFT ANTERIOR DESCENDING CORONARY DURING RADIOTHERAPY OF LEFT BREAST AND INTERNAL MAMMARY NODES
40. Blood Vessel Invasion on Pre Treatment Biopsies Predicted Poor Prognosis in Patients with Advanced Non–small-cell Lung Carcinoma Treated with Radio and Chemotherapy
41. Radiothérapie externe ou surveillance des séminomes testiculaires de stade 1 : comparaison des doses d’irradiation délivrées au testicule restant
42. Chimioradiothérapie des cancers bronchiques non à petites cellules – la présence d’emboles sur biopsies est un facteur pronostique des cancers
43. 161 Combining the adhesion pathway inhibition with radiotherapy – from the bench to the clinic
44. BLOOD VESSEL INVASION PREDICTED POOR PROGNOSIS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CARCINOMA TREATED WITH RADIO AND CHEMO-THERAPY
45. α3 integrin/FGF-2 expression profile: signature of local progression after chemo- radiotherapy for patients with NSCLC
46. L'expression deFGF-2 prédit laréponse tumorale etlecontrôle local descancers bronchiques non àpetites cellules après chimioradiothérapie
47. 1208P - Continuous Infusion of Cilengitide with Radio-Chemotherapy in Stage III Nsclc: a Phase I Study
48. The prognostic significance of lymphovascular invasion on biopsy specimens in lung cancer treated with definitive chemoradiotherapy.
49. Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer.
50. Adrénaline et dispositifs auto-injectables à usage unique dans le traitement du choc anaphylactique
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.